Rationales for Non-standard GBCA Dosing—Low?—High?—When? and Why?
For over 34 years, there has been a consistent demand to lower GBCA doses, with an increasing number of rationales over time. The high-relaxivity, low-dose mGBCAs show promise for reducing Gd dose while maintaining high image quality, potentially defining a new standard dose.
Authors
- Michael Blankenburg (ORCID: https://orcid.org/0000-0003-3886-1052)
- Imran Siddiqui (ORCID: https://orcid.org/0000-0002-6792-8730)
- Jan Endrikat (ORCID: https://orcid.org/0000-0001-6063-5014)
- Hassan Khater
Institutions
- Bayer (United States) (US)
- Bay Medical Center (US)
- Bayer (Germany) (DE)
- Saarland University (DE)
Publication Details
- Journal
- Investigative Radiology
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1097/rli.0000000000001259
- Citations
- 1
- Primary Topic
- Lanthanide and Transition Metal Complexes
- Type
- article
- Field-Weighted Citation Impact
- 0.52